Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | EVP & Chief People Officer | August 06, 2026 | August 10, 2026 |
| ITT INC.ITT · Entity 8806 | See Remarks | May 21, 2018 | May 22, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date August 06, 2026 · Filed August 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,051 |
Ending reported balance
After 2026-08-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-06 · Exercise / conversion · Acquired 4,179 · Balance 34,230 Row 2 · 2026-08-06 · Sale · Disposed 4,179 · Balance 30,051 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $179.66 · Expires 2030-05-29 | Direct | 0 |
Reported balance
After 2026-08-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-06 · Exercise / conversion · Disposed 4,179 · Balance 0 |
ITT INC.
Report date May 21, 2018 · Filed May 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,408.053 |
Last balance in matching sequence
After 2018-05-21 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2018-05-21 · Exercise / conversion · Acquired 7,640 · Balance 23,048.053 F1: Includes 12.053 shares under a dividend reinvestment plan. Row 2 · 2018-05-21 · Sale · Disposed 7,640 · Balance 15,408.053 F2: This price represents the approximate weighted average price per share of sales of common stock of ITT Inc. (the "Issuer"), which were executed at prices ranging from $55.13 to $55.19 per share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F1: Includes 12.053 shares under a dividend reinvestment plan. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.52 · Expires 2025-02-25 | Direct | 0 |
Reported balance
After 2018-05-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-05-21 · Exercise / conversion · Disposed 7,640 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 12.053 shares under a dividend reinvestment plan.
F2: This price represents the approximate weighted average price per share of sales of common stock of ITT Inc. (the "Issuer"), which were executed at prices ranging from $55.13 to $55.19 per share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2022 Filed Feb 1, 2022 22:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 343 | $329.76 | $113,107.68 |
DisclosureSEC source: 0001127602-22-002803 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,950 Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 22:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 2,395 | $312.24 | $747,814.80 |
DisclosureSEC source: 0001127602-22-002803 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,293 Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 22:47 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 6,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-002803 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,688 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 1,392 | $0.00 Strike: $179.66 | $0.00 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · derivative · entry 7 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,179 Underlying: Common Stock · 1,392 shares Expires 2030-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,380 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · derivative · entry 6 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,381 Underlying: Common Stock · 3,380 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,145 | $0.00 Strike: $124.13 | $0.00 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · derivative · entry 5 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,145 Underlying: Common Stock · 2,145 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 6,917 | $415.24 | $2,872,235.83 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · nonDerivative · entry 4 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,386 F1 · price: This transaction was executed in multiple trades at prices ranging from $415 to $415.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 1,392 | $179.66 | $250,086.72 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,303 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,380 | $144.67 | $488,984.60 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 19:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,145 | $124.13 | $266,258.85 |
DisclosureSEC source: 0001127602-21-023848 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2021 Filed Jun 1, 2021 21:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 127 | $337.99 | $42,924.73 |
DisclosureSEC source: 0001127602-21-018561 · form4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,386 Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 21:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 3,110 | $337.99 Strike: $337.99 | $1,051,148.90 |
DisclosureSEC source: 0001127602-21-018561 · form4.xml · derivative · entry 3 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,110 Underlying: Common Stock · 3,110 shares Expires 2031-05-28 F2 · shares: Stock Options vest as follows: 777 on May 28, 2022, 778 on May 28, 2023, 777 on May 28, 2024 and 778 on May 28, 2025. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 21:56 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018561 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,513 F1 · shares: Unvested restricted stock units vest as follows: 251 on May 28, 2022, 252 on May 28, 2023, 251 on May 28, 2024 and 252 on May 28, 2025. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 15:33 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 121 | $289.55 | $35,035.55 |
DisclosureSEC source: 0001127602-21-007511 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,507 Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 16:41 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 251 | $259.05 | $65,021.55 |
DisclosureSEC source: 0001127602-21-003432 · form4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · EVP & Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,628 Read SEC document |
| May 21, 2018 Filed May 22, 2018 20:47 UTC | ITT INC. ITT · Entity 8806 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,640 | $0.00 Strike: $41.52 | $0.00 |
DisclosureSEC source: 0000899243-18-013703 · doc4.xml · derivative · entry 3 Creamer Victoria L · CIK 0001632780 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,640 shares Expires 2025-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 22, 2018 20:47 UTC | ITT INC. ITT · Entity 8806 | SaleCommon Stock | 7,640 | $55.16 | $421,433.86 |
DisclosureSEC source: 0000899243-18-013703 · doc4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,408.053 F2 · price: This price represents the approximate weighted average price per share of sales of common stock of ITT Inc. (the "Issuer"), which were executed at prices ranging from $55.13 to $55.19 per share. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F1 · balance_after: Includes 12.053 shares under a dividend reinvestment plan. Read SEC document |
| May 21, 2018 Filed May 22, 2018 20:47 UTC | ITT INC. ITT · Entity 8806 | Exercise / conversionCommon Stock | 7,640 | $41.52 | $317,212.80 |
DisclosureSEC source: 0000899243-18-013703 · doc4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,048.053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 12.053 shares under a dividend reinvestment plan. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 00:42 UTC | ITT INC. ITT · Entity 8806 | Tax withholdingCommon Stock | 3,237 | $52.99 | $171,528.63 |
DisclosureSEC source: 0000899243-18-005886 · doc4.xml · nonDerivative · entry 3 Creamer Victoria L · CIK 0001632780 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,396 F3 · price: Reflects the withholding of (i) 1,288 shares of common stock to pay the tax liability incident to the settlement of performance units on February 26, 2018, as described in footnote (2) above, (ii) 1,086 shares of common stock to pay the tax liability incident to the vesting on February 25, 2018 of restricted stock units granted under the Plan pursuant to an employment agreement on February 25, 2015 and (iii) 863 shares of common stock to pay the tax liability incident to the vesting on February 25, 2018 of restricted stock units granted pursuant to an annual grant under the Plan on February 25, 2015. The number of shares withheld was determined on February 27, 2018 based on the average of the high/low price of the Issuer's common stock on February 26, 2018. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:42 UTC | ITT INC. ITT · Entity 8806 | GrantCommon Stock | 3,143 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-005886 · doc4.xml · nonDerivative · entry 2 Creamer Victoria L · CIK 0001632780 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,633 F2 · price: Acquired upon the settlement of performance units granted on February 25, 2015 under the ITT Inc. 2011 Omnibus Incentive Plan (the "Plan") as a result of the satisfaction of the performance criteria underlying the award. Read SEC document |
| February 26, 2018 Filed Mar 1, 2018 00:42 UTC | ITT INC. ITT · Entity 8806 | GrantCommon Stock | 3,615 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-005886 · doc4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,490 F1 · shares: Reflects an award of restricted stock units, all of which are scheduled to vest on February 26, 2021. Read SEC document |
| February 23, 2017 Filed Feb 25, 2017 02:07 UTC | ITT INC. ITT · Entity 8806 | GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-005342 · doc4.xml · nonDerivative · entry 1 Creamer Victoria L · CIK 0001632780 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 F1 · shares: Reflects an award of restricted stock units, all of which are scheduled to vest on February 23, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.